ONK Therapeutics is dedicated to optimizing a next generation of off-the-shelf, dual-targeted NK cell therapies for patients with hematological malignancies and solid tumors.
ONK Therapeutics is a privately held company, founded in 2015 based on the NK cell and apoptosis research of its founder Prof M O’Dwyer. MD and collaborators at National University of Ireland, Galway.The company’s unique approach harnesses the inna...
ONK Therapeutics is dedicated to optimizing a next generation of off-the-shelf, dual-targeted NK cell therapies for patients with hematological malignancies and solid tumors.
ONK Therapeutics is a privately held company, founded in 2015 based on the NK cell and apoptosis research of its founder Prof M O’Dwyer. MD and collaborators at National University of Ireland, Galway.The company’s unique approach harnesses the innate biology of NK cells, which are optimized through its proprietary platform, introducing genetic modifications to improve both functionality and cytotoxicity.
Sponsored Ad
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.